Pay in 4 interest-free payments of $6.86 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Kadono Y, Nakamura Y, Ogawa Y, et al
Several factors may contribute to dizziness in patients taking GLP-1 medications: Hypoglycaemia (low blood glucose) particularly when GLP-1 agonists are used alongside other glucose-lowering medications such as sulphonylureas or insulin Dehydration resulting from reduced fluid intake due to decreased appetite or from gastrointestinal side effects such as nausea, vomiting, or diarrhoea Orthostatic hypotension a drop in blood pressure upon standing, which may occur due to volume depletion or rapid weight loss Reduced caloric intake significant appetite suppression may lead to inadequate nutrition, potentially causing weakness and dizziness The frequency and severity of dizziness vary between individuals and specific GLP-1 products
However, some studies show that semaglutide (the active ingredient in Wegovy) may actually lower the risk of anxiety, especially in people with diabetes
These drugs improve glycemic control, promote weight loss, and even reduce cardiovascular risk
If you have recently started any new medications, this warrants discussion with your GP or diabetes specialist
US$ 22.62
US$ 28.18
US$ 26.39
US$ 23.79
US$ 21.89
US$ 28.45
